Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis [Phase 1, Phase 2]

View source ↗

Summary

A Clinical Trial Update reports that apigenin may improve organ function in elderly patients with sepsis and septic shock, across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apigenin (apigenin)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Sepsis, Septic Shock | Phase 1, Phase 2 | Status: COMPLETED